To comply with FTC regulations, all links on this site could lead to commissions paid to the publisher. Please see Advertising Disclosure in sidebar.
COLUMBIA, MO ― Obstructive sleep apnea (OSA) is a chronic sleep condition affecting more than one billion people worldwide. Evidence suggests OSA can alter the gut microbiome (GM) and may promote OSA-associated co-morbidities, including diabetes, hypertension and cognitive problems. Researchers from the University of Missouri School of Medicine and MU Health Care have discovered how OSA-related sleep disturbances affect the gut microbiome in mice and how transplanting those gut bacteria into other mice can cause changes to sleep patterns in the recipient mice.
David Gozal, MD, the Marie M. and Harry L. Smith Endowed Chair of Child Health at the MU School of Medicine, said the study shows the gut microbiome plays a major role in sleep regulation. This ultimately could translate into treatments that target the gut microbiome in humans with OSA.
“By manipulating the gut microbiome, or the byproducts of the gut microbiota, we would be in a position to prevent or at least palliate some of the consequences of sleep apnea,” said Gozal, the lead author of the study. “For example, if we combine continuous positive airway pressure (CPAP) with customized probiotics that change the patient’s gut microbiome, we might be able to eliminate some of the tiredness and fatigue and reduce the likelihood of the comorbidities associated with OSA that affect cognition, memory, cardiovascular disease or metabolic dysfunction. If we can do any one of those things, then this is a major movement forward in the way we treat OSA.”
The study exposed male mice to either room air or intermittent hypoxia — a condition in which the body doesn’t get enough oxygen — designed to mimic OSA. After six weeks, researchers collected fecal material from all of the rodents. A third group of mice was divided up and given either a fecal transplant from the mice breathing room air or those exposed to intermittent hypoxia. The transplanted mice underwent sleep recordings for three consecutive days. Researchers found the mice who received transplants from the intermittent hypoxia group slept longer and slept more often during their normal period of wakefulness, suggesting increased sleepiness.
Big Tech is using NewsGuard to censor us severely reducing our revenue. You can support our mission of truthful reporting by making a contribution. Honest journalism is incredibly important to our democracy; we refuse to let Silicon Valley crush us into just another regurgitated, propaganda driven, echo-chamber of lamestream media and we need your support. You can also help by signing up for our featured story emails.
“This is the first study that evaluated sleep in naïve mice subjected to a fecal microbiome transplant from mice exposed to intermittent hypoxia,” Gozal said. “The fecal microbiome analysis showed profile differences between the mice transplanted from intermittent hypoxia donor mice versus those exposed to room air, indicating that the transplant altered the GM of the recipient mice.”
Emerging evidence suggests the GM can influence health and sleep quality through the brain-gut microbiome axis (BGMA). The next step is to study the mechanism involved in the relationship between the brain and the gut to determine how changes in the gut microbiome can affect sleep structure and, in turn, how OSA can contribute to co-morbidities.
In addition to Gozal, the study authors include fellow MU School of Medicine collaborators Mohammad Badran, PhD, Child Health Research Institute; and Abdelnaby Khalyfa, PhD, associate research professor. Also contributing to the report was Aaron Ericsson, DVM, of the MU College of Veterinary Medicine.
The study, “Fecal microbiota transplantation from mice exposed to chronic intermittent hypoxia elicits sleep disturbances in naïve mice,” was recently published by the journal Experimental Neurology. Research reported in this publication was supported by grants from the National Institutes of Health and a grant from the University of Missouri. The contents of this publication do not necessarily represent the official views of the funding agencies.
About University of Missouri Health Care and the University of Missouri School of Medicine
MU Health Care and the MU School of Medicine form an academic health system dedicated to patient care, research and education. Caring for patients from each of Missouri’s 114 counties, both enterprises focus on advancing care for the simplest and most complex conditions, researching breakthroughs for today’s most prevalent health problems and training the next generation of health care providers. With a combined expertise of nearly 7,000 faculty physicians, researchers, nurses and other health care professionals, the academic health system educates over 2,000 students, residents and fellows each year and serves nearly 240,000 patients. For more information, visit muhealth.org and medicine.missouri.edu.